BDTX
Black DiamondยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BDTX Profile
Black Diamond Therapeutics, Inc.
A company that developing small molecule, tumor-agnostic therapies for cancers
Biological Technology
--
01/30/2020
NASDAQ Stock Exchange
24
12-31
Common stock
One Main Street, 14th Floor, Cambridge, Massachusetts 02142
--
Black Diamond Therapeutics, Inc., was incorporated in Delaware in December 2014. The company is a clinical-stage oncology company focused on developing MasterKey therapies for the treatment of patients with genetically defined tumors. The company's goal is to genetically define cancer-causing driver mutations in cancer patients where drugs do not exist.
